| ³«ºÅǯ·î |
³Ø²ñ̾ |
±é¼Ô |
±éÂê̾ |
| 1999ǯ2·î |
Âè70²óÆüËܾò½´ïɳزñ¡¡¶áµ¦»ÙÉôÎã²ñ |
¶â¼éÎÉ |
´Î±ê¥¦¥¤¥ë¥¹¥Þ¡¼¥«¡¼±¢À¤ÎËýÀ»ý³À´Î±ê¡ÊCPH¡Ë¤òÇØ·Ê¤È¤·¤Æ3ǯ¤Î·Ð²á¤ÇÁ£¼ðÍͲá·ÁÀ®¡ÊAH¡Ë¤«¤é´Î´â¡ÊHCC¡Ë¤Ø¤Î°Ü¹Ô¤¬¸«¤é¤ì¤¿°ì¾ÉÎã |
| 1999ǯ6·î |
Âè35²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
PEIT¼£ÎŸ塢´Î³°¤ËÇżïÀȯ°é¤·¤¿HCC¤Î°ì¾ÉÎã |
| 1999ǯ10·î |
Âè41²óÆüËܾò½´ïɳزñ |
¶â¼éÎÉ |
Èó£ÂÈó£Ã´Î´â¤Ë¤ª¤±¤ëTTV¤ÎÍÛÀΨ¤ÈÍ¢·ìÎò¤Î¸¡Æ¤―£Â¡¦£Ã´Î´â¤È¤ÎÈæ³Ó― |
| 1999ǯ10·î |
Âè63²óÆüËܾò½´ïÆâ»ë¶À³Ø²ñ¡¡¶áµ¦ÃÏÊý²ñ |
°ÂÆ£·ò¼£ |
±éÂê̾Èó¸ø³« |
| 1999ǯ12·î |
Âè33²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
±éÂê̾Èó¸ø³« |
| 1999ǯ12·î |
Âè33²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
´ÎºÙ˦´â¡ÊHCC¡Ë¤ËÂФ¹¤ë¥¨¥¿¥Î¡¼¥ëÃíÆþÎÅË¡¡ÊPEIT¡Ë¤Î¹çÊ»¾É―´Î³°ÇżïÀž°ÜÎã¤È´Î³°A-V¥·¥ã¥ó¥ÈÎã¤Ë¤Ä¤¤¤Æ |
| 1999ǯ12·î |
Âè33²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
°æËÜÊÙ |
honeymoon hepatitis¤È¤·¤ÆÈ¯¾É¤·¤¿HHV-6ñ³Ë¾É¤Î1Î㡾ÆÃ¤ËISHË¡¤Ë¤è¤ë¥¦¥¤¥ë¥¹´¶À÷ºÙ˦¤ÎƱÄê |
| 2000ǯ2·î |
Âè72²óÆüËܾò½´ïɳزñ¡¡¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
Lp-TAE¸å´ÎÇ¿áç¤òȯ¾É¤·¤¿´ÎºÙ˦´â¤Î°ìÎã |
| 2000ǯ4·î |
Âè86²óÆüËܾò½´ïɳزñÂç²ñ |
¶â¼éÎÉ |
£Ã·¿´Î±ê¤ËÂФ¹¤ëIFNÎÅË¡¸åÃø¸ú¤Ë¤â¤«¤«¤ï¤é¤º3ǯ¸å¡¢7ǯ¸å¤Ëȯ´â¤·¤¿´ÎºÙ˦´â¤Î°ì¾ÉÎã |
| 2000ǯ6·î |
Âè36²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
£Ã·¿´Î±ê¤ËÂФ¹¤ëIFNÅêÍ¿ÎãµÚ¤Ó£Ã·¿´Î¹ÅÊѤ˹çÊ»¤·¤¿¸¶È¯À¹Å²½ÀÃÀ´É±ê¤Î3¾ÉÎã |
| 2000ǯ6·î |
Âè36²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
ÌäÂê¾ÉÎ㸡Ƥ²ñ·Ð²á´Ñ»¡Ãæ¤ËCTAP½ê¸«¤Î±¢À²½¤Ëȼ¤¤ÉÔÌÀÎÆ²½¤·¤¿Ä㥨¥³¡¼·ëÀá¤Î°ì¾ÉÎã |
| 2000ǯ9·î |
Âè73²óÆüËܾò½´ïɳزñ¡¡¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
¹âÅ٤β«áÕ¤òÄ褷¹ÈÆÀ´Î²õ»à¤òȼ¤Ã¤¿µÞÀ´Î±êÁü¤Çȯ¾É¤·¤¿¹âÎð¼Ô¼«¸ÊÌȱÖÀ´Î±ê¡¦·¿¤Î°ìÎã |
| 2000ǯ9·î |
Âè37²óÆüËÜÊ¢ÉôµßµÞ°å³Ø²ñÁí²ñ |
¶ñ¸÷À® |
µÞÀÊ¢¾É¤ÈÊ¢ÉôÂçÆ°Ì®áîÀÚÇ÷ÇËÎö¤Î´ÕÊ̤˶ìθ¤·¤¿¾ÉÎã |
| 2000ǯ10·î |
Âè3²ó¹ñºÝ´Î¹ÅÊѴδ⥷¥ó¥Ý¥¸¥¦¥à |
¶â¼éÎÉ |
TTV-positivity and
transfusion history in non-B and non-C HCC compared
with HBV- and HCV-positive cases |
| 2000ǯ11·î |
Âè33²óÆüËܴΡ³Ø²ñÅìÉô²ñ |
¶â¼éÎÉ |
±éÂê̾Èó¸ø³« |
| 2001ǯ2·î |
Âè74²óÆüËܾò½´ïɳزñ¡¡¶áµ¦»ÙÉôÎã²ñ |
»°ÅÄ·ÉÆó |
·ìÀ¤Îç¹ÀÊ¢¿å¤òÄ褷¤¿ç¹²¾Àǹ˦¤Î°ìÎã |
| 2001ǯ4·î |
Âè87²óÆüËܾò½´ïɳزñÁí²ñ |
¶â¼éÎÉ |
Áá´ü´ÎºÙ˦´â¤Ë¤ª¤±¤ëĹ´üͽ¸å¤Î¸¡Æ¤ |
| 2001ǯ4·î |
Âè101²óÆüËܳ°²Ê³Ø²ñÁí²ñ |
¶ñ¸÷À® |
´§Æ°Ì®¥Ð¥¤¥Ñ¥¹½Ñ¤Ë¤ª¤±¤ëµõ·ìºÆÞõή¾ã³²¡Ý·ìÃæ»ÀÁÇÇ»ÅÙ¤ÈCaÙɹ³ºÞ¤Î¸úǽ |
| 2001ǯ5·î |
Âè37²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
±éÂê̾Èó¸ø³« |
| 2001ǯ5·î |
Âè29²óÆüËÜ·ì´É³°²Ê³Ø²ñ³Ø½ÑÁí²ñ |
¶ñ¸÷À® |
´§Æ°Ì®¥Ð¥¤¥Ñ¥¹½Ñ¤Ë¤ª¤±¤ëµõ·ìºÆÞõή¾ã³²―ºÆÞõή»þ·ìÃæ»ÀÁÇÇ»Å٤ȥ«¥ë¥·¥¦¥àÙɹ³ºÞ¤Î¸úǽ |
| 2001ǯ6·î |
Âè37²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
¥é¥¸¥ªÇȾƼÞÎÅË¡¡ÊRFA¡Ë¤Ë¤è¤ë¹çÊ»¾É¡¦ÃÀ´É»½ý¤Î°ì¾ÉÎã |
| 2001ǯ6·î |
Âè37²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
´Î±ê¥¦¥¤¥ë¥¹¥Þ¡¼¥«¡¼±¢À¤ÎËýÀ»ý³À´Î±ê¡ÊCPH¡Ë¤òÇØ·Ê¤È¤·¤Æ3ǯ¤Î·Ð²á¤ÇÁ£¼ðÍͲá·ÁÀ®(AH)¤«¤é´ÎºÙ˦´â¡ÊHCC¡Ë¤Ø¤Î°Ü¹Ô¤¬¸«¤é¤ì¤¿°ì¾ÉÎã |
| 2001ǯ9·î |
Âè75²óÆüËܾò½´ïɳزñ¡¡¶áµ¦»ÙÉôÎã²ñ |
Á°ÀîÍÛ»Ò |
´ÎºÙ˦´â¤ËÂФ¹¤ë¥é¥¸¥ªÇȾƼÞÎÅË¡¡ÊRFA¡Ë¤Î¸¡Æ¤ |
| 2001ǯ10·î |
DDW-JAPAN¡¡2001Âè5²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
±éÂê̾Èó¸ø³« |
| 2001ǯ10·î |
DDW-JAPAN¡¡2001Âè5²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
¿Ê¹Ô´Î´â¡ÊHCC¡Ë¤ËÂФ¹¤ëÀ¸Âδΰܿ¢¤Ë¤ª¤±¤ëÆâ²Ê°å¤ÎÁªÂò |
| 2001ǯ12·î |
Âè34²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ë´Î¹ÅÊѤˤߤé¤ì¤¿²á·ÁÀ®·ëÀá¤Î°ìÎã |
| 2001ǯ12·î |
Âè34²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
°æËÜÊÙ |
µÞÀȯ¾É¤·½Å¾ÉµÞÀ´Î±ê¤ÎÁÈ¿¥Áü¤òÄ褷¤¿¹âÎð¼Ô¼«¸ÊÌȱÖÀ´Î±êµ·¿¤Î2Îã |
| 2002ǯ2·î |
Âè76²óÆüËܾò½´ïɳزñ¡¡¶áµ¦»ÙÉôÎã²ñ |
Á°ÀîÍÛ»Ò |
ÂçIJ´â¤Îȯ°é¿ÊŸ¤ÈޱŽÎŽßŽÄް޼޽µÚ¤ÓºÙ˦Áý¿£¤Î´ØÍ¿¤Ë¤Ä¤¤¤Æ |
| 2002ǯ4·î |
Âè88²óÆüËܾò½´ïɳزñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤Ë¤ª¤±¤ë´Î»éËò½¤ÎÍ̵¤Ë¤è¤ëȯ´âΨµÚ¤Óȯ´â»þ¤ÎÉÂÍý³ØÅª¸¡Æ¤ |
| 2002ǯ5·î |
Âè38²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
CTAP½ê¸«ÍÛÀ²½(S7¡Ë4ǯ¸å¡¢AFP L3ʬ²èÍÛÀ²½3ǯ¸å¤ËS7¤Î¾Éô°Ì¤Ëȯ´â¤·¤¿Áá´üHCC¤Î°ì¾ÉÎã |
| 2002ǯ6·î |
Âè38²óÆüËܴΡ³Ø²ñÁí²ñ |
Á°ÀîÍÛ»Ò |
Áá´ü´ÎºÙ˦´â¡ÊHCC¡Ë¤Î¼£ÎÅÀ®ÀӤθ¡Æ¤¡ÝPEIT¼£ÎŤòÃæ¿´¤Ë¡Ý |
| 2002ǯ9·î |
Âè77²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
AMA¡¢¹³PDH¹³ÂΤϱ¢À¤Ç¤¢¤Ã¤¿¤¬IgA·¿OGDC¡¾E2¹³ÂΤ¬Ã±ÆÈ¤Ç¸¡½Ð¤µ¤ì¡¢¤«¤Ä¥·¥§¡¼¥°¥ì¥ó¾É¸õ·²¡¢CRST¾É¸õ·²¡¢ËýÀ´ØÀá¥ê¥¦¥Þ¥Á¤ò¹çÊ»¤·¤¿¡¢¸¶È¯ÀÃÀ½ÁÀ´Î¹ÅÊÑ¡¾¼«¸ÊÌȱֽÅÊ£¾É¸õ·²¤Î°ìÎã |
| 2002ǯ10·î |
DDW¡¾JAPAN2002¡¡Âè44²óÆüËܾò½´ïɳزñÂç²ñ |
¶â¼éÎÉ |
ÂçIJ´â´Îž°Ü¤Ë´Ø¤¹¤ë¥¢¥Ý¥È¡¼¥·¥¹¤ÈºÙ˦Áý¿£Ç½¤Î¸¡Æ¤ |
| 2002ǯ10·î |
DDW¡¾JAPAN2002¡¡Âè6²óÆüËܴΡ³Ø²ñÂç²ñ |
Á°ÀîÍÛ»Ò |
Liver enrichž¼Ì³ËÃÁÇòÀ÷¿§¡ÊHNF-4¦Á¡¢HNF-3¦Â¡Ë¤Ë¤è¤êstem cellͳÍè¤È¹Í¤¨¤é¤ì¤¿HCC¡¢CCC¡¡mixed
tumor |
| 2002ǯ10·î |
DDW-JAPAN2002¡¡Âè6²óÆüËܴΡ³Ø²ñÂç²ñ |
°æËÜÊÙ |
HCV´¶À÷¼Ô¤Ë¤ª¤±¤ë¥¦¥¤¥ë¥¹ÇÓ½üµÚ¤Ó»ý³¤Î¥á¥«¥Ë¥º¥à¤Ë´Ø¤¹¤ë¸¦µæ |
| 2002ǯ10·î |
DDW-JAPAN2002¡¡Âè6²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ë¿·ìÀ·ëÀáÉÂÊѤθ¡Æ¤ |
| 2002ǯ11·î |
Âè34²óÆüËܴΡ³Ø²ñÅìÉô²ñ |
¶â¼éÎÉ |
CTAP¤ÇÇ»À÷¤µ¤ìCTA¤Çperfusion defect¤ò¼¨¤·ÇØç¹Æ°Ì®¡¢ç¹Æ¬Æ°Ì®¤Î·ì´É°Û¾ï¤¬¸¶°ø¤È¹Í¤¨¤é¤ì¤¿S6
3cmÂç¹â¥¨¥³¡¼SOL¤Î°ì¾ÉÎã |
| 2002ǯ11·î |
Âè34²óÆüËܴΡ³Ø²ñÅìÉô²ñ
|
Á°ÀîÍÛ»Ò |
ºÆÈ¯¤ò·«¤êÊÖ¤·²èÁü¾åHCC¤È¤Î´ÕÊ̤¬º¤Æñ¤Ç¤¢¤Ã¤¿±ê¾ÉÀµ¶¼ðáç¤Î°ìÎã |
| 2003ǯ2·î |
Âè78²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
¹³LKM-1¹³ÂΤ¬¸¡½Ð¤µ¤ì¤¿µ·¿¼«¸ÊÌȱÖÀ´Î±ê¤Î£±Îã |
| 2003ǯ3·î |
Âè70²óÆüËܾò½´ïÆâ»ë¶À³Ø²ñ¶áµ¦ÃÏÊý²ñ |
°ÂÆ£·ò¼£ |
¼ê½ÑÎò¤Î¤Ê¤¤¥¤¥ì¥¦¥¹¾ÉÎã¤Î¸¡Æ¤ |
| 2003ǯ4·î |
Âè89²óÆüËܾò½´ïɳزñÁí²ñ |
¶â¼éÎÉ |
¶Ë¾®´ÎºÙ˦´â¡ÊHCC¡Ë¤ÎPEIT¼£ÎÅÀ®ÀӤθ¡Æ¤ |
| 2003ǯ5·î |
Âè39²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
CTAP½ê¸«ÍÛÀ²½5,6ǯ¸å¡¢AFP¡¡L3ʬ²èÍÛÀ²½3,4ǯ¸å¤Ë¤½¤ì¤¾¤ìS7¤Ë¹âʬ²½´â¡¢S3¤ËÃæÊ¬²½´â¤¬¡¢°Û»þÀȯ´â¤·¤¿HCC¤Î°ì¾ÉÎã |
| 2003ǯ5·î |
Âè39²óÆüËܴΡ³Ø²ñÁí²ñ¡Ê¥é¥ó¥Á¥ç¥ó¥»¥ß¥Ê¡¼¡Ë |
¶â¼éÎÉ |
Ãϰè°ìÈÌɱ¡¤Ë¤ª¤±¤ë´Î¡Î×¾²15ǯ¤Î·Ð¸³ |
| 2003ǯ5·î |
Âè39²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
Î×¾²É´üµ¡¢¶Ë¾®´ÎºÙ˦´â¡ÊHCC¡Ë¤ÎPEIT¼£ÎÅÀ®ÀӤθ¡Æ¤ |
| 2003ǯ5·î |
Âè39²óÆüËܴΡ³Ø²ñÁí²ñ |
°æËÜÊÙ |
µ·¿¼«¸ÊÌȱÖÀ´Î±ê¤Ë¤ª¤±¤ë¹³LKM-1¹³ÂΤθ¡½Ð¡¢ÍÛÀÎã¤Î¸¡Æ¤ |
| 2003ǯ6·î |
Âè39²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤òÇØ·Ê¤Ëstem cellͳÍè¤È¹Í¤¨¤é¤ì¤¿HCC¡¦CCC¡¡mixed¡¡tumor
|
| 2003ǯ6·î |
Âè39²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
B·¿µÚ¤ÓC·¿´Î¹ÅÊѤòÇØ·Ê¤ËȯÀ¸¤·¤¿HCC¡¦CCC¡¡mixed¡¡tumor¤Î2¾ÉÎã |
| 2003ǯ9·î |
Âè79²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
ÉØÌÚ½¨°ì |
ŽØŽÊŽÞŽËŽÞŽØŽÝÊ»ÍÑÎÅË¡Ãæ¤ËÌÖËìÃæ¿´ÀÅÌ®Êĺɾɤò¹çÊ»¤·¤¿°ì¾ÉÎã |
| 2003ǯ10·î |
Âè71²ó¾Ã²½´ïÆâ»ë¶À³Ø²ñ¶áµ¦ÃÏÊý²ñ |
»°ÅÄ·ÉÆó |
¼£ÎÅÊý¿Ë¤Î·èÄê¤Ë¶ìθ¤·¤¿Â¿È¯ÀÂçIJ¥Ý¥ê¡¼¥×¤Î°ìÎã |
| 2003ǯ10·î |
Âè7²óÆüËܴΡ³Ø²ñÂç²ñ |
¶â¼éÎÉ |
IFN¤È¥ê¥Ð¥Ó¥ê¥óÊ»ÍÑÎÅË¡¤ÎÉûºîÍѤθ¡Æ¤ |
| 2003ǯ11·î |
Âè35²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
È󥢥륳¡¼¥ëÀ»éËÃÀ´Î±ê¡ÊNASH¡Ë¤ÎÎ×¾²ÉÂÍý³ØÅª¸¡Æ¤¡Ý»éËôΤȤÎÈæ³Ó¡Ý |
| 2003ǯ11·î |
Âè35²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
CTAP¤Ë¤ÆÇ»À÷¡¢CTA¤Ë¤ÆË³·ìÀ½ê¸«¤òÄ褷¤¿¹âʬ²½·¿HCC¤Î°ì¾ÉÎã |
| 2003ǯ11·î |
Âè35²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
°æËÜÊÙ |
¹³LKM-1¹³ÂΤ¬¸¡½Ð¤µ¤ì¤¿£É·¿¼«¸ÊÌȱÖÀ´Î±ê¤Î2Îã |
| 2004ǯ2·î |
Âè80²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
ç¹Æ¬Æ°Ì®-ÌçÌ®¥·¥ã¥ó¥È¤òͤ·¤¿Æñ¼£ÀÊ¢¿å¤ËÂФ·¥Ç¥ó¥Ð¡¼Ê¢¹Ð¡¦ÀÅÌ®¥·¥ã¥ó¥È½Ñ¤òÍѤ¤¤¿¾ÉÎã |
| 2004ǯ6·î |
Âè40²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëIFN¦Á-2b¡Ü¥ê¥Ð¥Ó¥ê¥óÎÅË¡¤Ë¤ª¤±¤ë¡¢IFN¦ÂÊ»ÍÑÎÅË¡¤ÎÎ×¾²Åª°ÕµÁ¤È¥¦¥¤¥ë¥¹¸º¾¯Î¨¤Î¸¡Æ¤ |
| 2004ǯ6·î |
Âè40²óÆüËܴΡ³Ø²ñÁí²ñ |
¶â¼éÎÉ |
ÈóÄ귿ŪÂç·¿¹âʬ²½·¿´Î´â2ÀÚ½üÎã¤ÎÎ×¾²ÉÂÍý³ØÅª¸¡Æ¤ |
| 2004ǯ6·î |
Âè40²óÆüËܴΡ³Ø²ñÁí²ñ |
°æËÜÊÙ |
¹³¥»¥ó¥È¥í¥á¥¢¹³ÂΤ¬Ã±ÆÈÍÛÀ¤Ç¾¤ÎÀ÷¿§·¿¤Î¹³³Ë¹³ÂΤ¬±¢À¤Î£É·¿¼«¸ÊÌȱÖÀ´Î±ê |
| 2004ǯ6·î |
Âè40²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
´Î¥«¥ë¥Á¥Î¥¤¥É¼ðáç¤Î2ÀÚ½üÎã-ÁÈ¿¥È¯À¸¤òÃæ¿´¤Ë- |
| 2004ǯ6·î |
Âè40²óÆüËܴδ⸦µæ²ñ |
Á°ÀîÍÛ»Ò |
ž°ÜÀ´Î´â¤ËÂФ¹¤ëRFA¼£ÎŤÎŬ±þ¤È¸Â³¦-ÂçIJ´â´Îž°ÜÆó¾ÉÎã¤Î¸¡Æ¤- |
| 2004ǯ6·î |
Âè40²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
¶Ë¾®´ÎºÙ˦´â¡ÊHCC¡Ë¤ÎLpTAE¡ÜPEIT¼£ÎÅÀ®ÀӤθ¡Æ¤ |
| 2004ǯ9·î |
Âè81²óÆüËܾò½´ïɳزñ |
ÉØÌÚ½¨°ì |
·«¤êÊÖ¤¹»ÉÀĻܹԤˤè¤ë´¶À÷¤Ë¤è¤êȯ¾É¤·¤¿C·¿µÞÀ´Î±ê¤Î°ì¾ÉÎã |
| 2004ǯ9·î |
ISBRA¡¡Satellite¡¡Symposium |
¶â¼éÎÉ |
Hypervascular liver nodules in heavy drinkers
of alcohol |
| 2004ǯ10·î |
Âè3²ó¡¡ÆüËܴΡ³Ø²ñ¡¡Ž¼ŽÝޏŽÞŽÙŽÄŽËŽßޝޏ¡¡Ž¶ŽÝŽÌާŽÚŽÝ޽ |
¶â¼éÎÉ |
Comparison of clinicopathological features of
nonalcoholic steatohepatitis with nonalcoholic fatty
liver |
| 2004ǯ10·î |
DDW¡¡Japan2004 |
¶â¼éÎÉ |
ž°ÜÀ´Î´â¤ËÂФ¹¤ëRFA¼£ÎŤÎŬ±þ¤È¸Â³¦ |
| 2004ǯ10·î |
DDW¡¡Japan2004 |
»°ÅÄ·ÉÆó |
Ëܱ¡¤Ë¤ª¤±¤ëPEG¤Î»Ü¹Ô·Ð¸³¡¡¹çÊ»¾É¤È¤½¤ÎÂкö |
| 2004ǯ10·î |
DDW¡¡Japan2004 |
¶â¼éÎÉ |
NASH¤ÎÉÂÂ֤ˤª¤±¤ëapoptosisµÚ¤ÓºÙ˦Áý¿£³èÀ¤Î°ÕµÁ |
| 2005ǯ2·î |
Âè82²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
¶â¼éÎÉ |
µÞÀ´Î±ê¤è¤êËýÀ²½¤ò³ÎÄꤷ¤¨¤¿genotype C, B·¿µÞÀ´Î±ê¤Î°ì¾ÉÎã |
| 2005ǯ2·î |
Âè82²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
°ÂÆ£·ò¼£ |
Åö±¡¤Ë¤ª¤±¤ëÁá´ü´ÎºÙ˦´â¤ËÂФ¹¤ëPEIT¤ÎĹ´ü¼£ÎÅÀ®ÀÓ |
| 2005ǯ3·î |
Âè74²óÆüËܾò½´ïÆâ»ë¶À³Ø²ñ¶áµ¦ÃÏÊý²ñ |
ÉØÌÚ½¨°ì |
¼ðáî·ÁÀ®Àç¹±ê¤È¤Î´ÕÊ̤ËEUS-FNA¤¬ÍÍѤǤ¢¤Ã¤¿ç¹Æ¬Éôç¹´É´â¤Î°ìÎã |
| 2005ǯ4·î |
Âè91²óÆüËܾò½´ïɳزñÁí²ñ |
¶â¼éÎÉ |
C·¿´Î¹ÅÊѤòÇØ·Ê¤ËCTAP¤Ë¤ÆÇ»À÷¡¢CTA¤Ë¤ÆË³·ìÀ½ê¸«¤òÄ褷¤¿2¾ÉÎã |
| 2005ǯ6·î |
Âè41²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
ÈóBÈóC´Î´â¤Ë¤ª¤±¤ëÍ¢·ìÎò¤Î¸¡Æ¤¤ÈTTV¤Î´ØÍ¿ |
| 2005ǯ6·î |
Âè41²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤòÇØ·Ê¤Ëȯ¾É¤·¤¿º®¹ç·¿´Î´â¤Î°ì˶¸¡¾ÉÎã |
| 2005ǯ6·î |
Âè41²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
ÆÃ°Û¤Êž°ÜÍͼ°¤òÄ褷¤¿´ÎºÙ˦´â¤ÎÆó¾ÉÎã |
| 2005ǯ6·î |
Âè41²óÆüËܴδ⸦µæ²ñ |
ÉØÌÚ½¨°ì |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN¦Á-2a¤Ë¤ª¤±¤ëpolaprezinc¤Î·ìµå¸º¾¯¤ËÂФ¹¤ë¸ú²Ì¡ÊÅêÍ¿12½µ¤Ç¤Î¸¡Æ¤¡Ë |
| 2005ǯ6·î |
Âè41²óÆüËܴδ⸦µæ²ñ |
¶â¼éÎÉ |
´Î´â¤ËÂФ¹¤ë°Ü¿¢°åÎŤò¤á¤°¤ëÀ¸Ì¿ÎÑÍý³ØÅª¹Í»¡ |
| 2005ǯ6·î |
Âè176²óÆüËÜÆâ²Ê³Ø²ñÃÏÊý²ñ |
ÉØÌÚ½¨°ì |
¿ºÌ¤Ê¹çÊ»¾É¤òʻȯ¤·¤¿¥ì¥¸¥ª¥Í¥éÇÙ±ê¤Î°ìÎã |
| 2005ǯ9·î |
Âè83²óÆüËܾò½´ïɳزñ¶áµ¦»ÙÉôÎã²ñ |
»°ÅÄ·ÉÆó |
£Ã£Å£Á¾å¾º¤ò·Àµ¡¤È¤·¤Æ¼£ÎÅ¿ÇÃǤλê¤Ã¤¿²ÄưÀ¤ÎÈó¾ï¤ËÎɹ¥¤Ç¤¢¤Ã¤¿Ãî¿â¼ðáç¤Î°ìÎã |
| 2005ǯ9·î |
Âè177²óÆüËÜÆâ²Ê³Ø²ñ¶áµ¦ÃÏÊý²ñÎã²ñ |
¹¿¡¡îë¼÷ |
¿Í¹©¸ÆµÛ´ÉÍýÃæ¤ÎmidazolamÅêÍ¿¤Ë¤è¤êµÞÀ´ÎÉÔÁ´¤òȯ¾É¤·¤¿µÞÀ¥ê¥ó¥ÑÀÇò·ìɤξÉÎã |
| 2005ǯ10·î |
DDW¡¡Japan¡¡2005 |
¶â¼éÎÉ |
È󥢥륳¡¼¥ëÀ»éËÃÀ´Î±ê¡ÊNASH¡Ë¤ÎÎ×¾²ÉÂÍý³ØÅª¸¡Æ¤¡Ý»éËôΡÊFL¡Ë¤È¤ÎÈæ³Ó |
| 2005ǯ10·î |
DDW¡¡Japan¡¡2005 |
¶â¼éÎÉ |
PEG-IFN¦Á2a¤Î͸úÀ¡¦°ÂÁ´À¤È°ÌÃ֤Ť±¤Ë¤Ä¤¤¤Æ |
| 2005ǯ10·î |
DDW¡¡Japan¡¡2005 |
ÉØÌÚ½¨°ì |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëPEG-IFN¦Á2aÎÅË¡¤Ë¤ª¤±¤ë¼£ÎŸú²Ì¤ËµÚ¤Ü¤¹ISDR¤Î´ØÍ¿ |
| 2005ǯ11·î |
ÆüËÜÎ×¾²·ì±Õ³Ø²ñÎã²ñ |
¹¿¡¡îë¼÷ |
ÆÃħŪÀ÷¿§ÂΞºÂ¡Êt¡Ê1:7¡Ë¡Ë¤òǧ¤áËö¾¿·ì¹¥»ÀµåÁý¿¤ª¤è¤ÓÃ×̿Ū´Ö¼ÁÀÇÙ±ê¤òʻȯ¤·¤¿MDS¤Î¾ÉÎã |
| 2005ǯ11·î |
Âè36²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
PEG-IFN¦Á-2a¤Î͸úÀ¡¦°ÂÁ´À¤È°ÌÃ֤Ť±¤Ë¤Ä¤¤¤Æ |
| 2005ǯ11·î |
Âè36²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
´Î¸¶È¯À¥«¥ë¥Á¥Î¥¤¥É¼ðáç¤Î2¾ÉÎã |
| 2005ǯ11·î |
Âè36²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
°æËÜÊÙ |
¸¶È¯ÀÈ󥢥륳¡¼¥ëÀ»éËÃÀ´Î±ê¤Èµ·¿¼«¸ÊÌȱÖÀ´Î±ê¤Î°ì¹çÊ»Îã-ÆÃ¤Ë´Î¤ÎÉÂÍýÁÈ¿¥³ØÅª¸¡Æ¤ |
| 2005ǯ11·î |
Âè36²óÆüËܴΡ³Ø²ñÀ¾Éô²ñ |
¶â¼éÎÉ |
C·¿ËýÀ´Î±ê¤ËÂФ¹¤ëIFNÎÅË¡Ãæ¤ËÌÖËìÃæ¿´ÀÅÌ®Êĺɾɤò¹çÊ»¤·¤¿2¾ÉÎã |
| 2005ǯ12·î |
Âè4²óÆüËܴΡ³Ø²ñ¥·¥ó¥°¥ë¥È¥Ô¥Ã¥¯¥«¥ó¥Õ¥¡¥ì¥ó¥¹ |
¶â¼éÎÉ |
Long-term outcome of PEIT for small HCC less than
15mm |